Anlon Healthcare working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
393.00×
220.06×
146.53×
466.53×
0.86×
0.46×
−2.73×
−1.67×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹130 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Inventory Days (DIO)393.00
Receivable Days (DSO)220.06
Payable Days (DPO)146.53
Cash Conversion Cycle (days)466.53
Working Capital Turnover0.86
Asset Turnover0.46
Cash Conversion (CFO/Net Income)-2.73
CFO/EBITDA-1.67
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.